Alnylam Pharmaceuticals Inc Cash Flow Quality Index
Alnylam Pharmaceuticals Inc cash flow quality index. Alnylam Pharmaceuticals Inc (ALNY) has a Cash Flow Quality Index of 0.88x as of December 2025. Operating cash flow of $163.56 Million is below net income of $186.42 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ALNY cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Alnylam Pharmaceuticals Inc (2025–2025)
Cash flow quality index of Alnylam Pharmaceuticals Inc from 2025 to 2025. Historical Cash Flow Quality Index for Alnylam Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. See ALNY equity to assets ratio to measure how much of total assets are equity-financed.
Alnylam Pharmaceuticals Inc Cash Flow Quality Index by Year (2025–2025)
Alnylam Pharmaceuticals Inc cash flow quality index by year from 2025 to 2025. Year-by-year earnings quality comparison for Alnylam Pharmaceuticals Inc. For the full cash flow conversion analysis, see Alnylam Pharmaceuticals Inc (ALNY) cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.67x | $524.08 Million | $313.75 Million | — |